Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections
- PMID: 3059922
- DOI: 10.1111/j.1749-6632.1988.tb42104.x
Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections
Abstract
In summary, we have shown that MA is toxic to both 5-HT and DA cells and we have proposed a mechanism that would account for this response, namely, the conversion of the transmitters to neurotoxins. In addition, brain depletions of DA seem regionally specific with larger depletions occurring in some areas than in others. The depletions, however, do not seem to depend entirely on the nuclei of origin, that is, substantia nigra versus VTA. 5-HT was depleted by different amounts in the various regions examined and the 5-HT depletions, although proportional to the DA depletions, were consistently greater. The reasons for this differential sensitivity of the 5-HT and DA systems to the toxic effect of MA is speculative, but may be related to the differential formation of toxins due to the differing availability of oxygen and superoxides at serotonergic and dopaminergic synapses.
Similar articles
-
Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(6):861-72. doi: 10.1016/0278-5846(91)90014-r. Prog Neuropsychopharmacol Biol Psychiatry. 1991. PMID: 1722342
-
Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.J Neural Transm (Vienna). 1998;105(6-7):749-67. doi: 10.1007/s007020050093. J Neural Transm (Vienna). 1998. PMID: 9826116
-
Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.Eur J Pharmacol. 1989 Oct 10;169(2-3):321-4. doi: 10.1016/0014-2999(89)90031-9. Eur J Pharmacol. 1989. PMID: 2530097
-
Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.Brain Res. 1986 Jun;396(2):157-98. doi: 10.1016/s0006-8993(86)80193-7. Brain Res. 1986. PMID: 3527341 Review.
-
Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system.Ann N Y Acad Sci. 2000 Sep;914:112-26. doi: 10.1111/j.1749-6632.2000.tb05189.x. Ann N Y Acad Sci. 2000. PMID: 11085314 Review.
Cited by
-
Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons.Neurobiol Dis. 2021 Aug;156:105409. doi: 10.1016/j.nbd.2021.105409. Epub 2021 May 31. Neurobiol Dis. 2021. PMID: 34082123 Free PMC article.
-
A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats.Psychopharmacology (Berl). 2013 Feb;225(3):753-63. doi: 10.1007/s00213-012-2864-0. Epub 2012 Sep 25. Psychopharmacology (Berl). 2013. PMID: 23007601 Free PMC article.
-
Neurotoxins: free radical mechanisms and melatonin protection.Curr Neuropharmacol. 2010 Sep;8(3):194-210. doi: 10.2174/157015910792246236. Curr Neuropharmacol. 2010. PMID: 21358970 Free PMC article.
-
Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice.Int J Mol Sci. 2023 Aug 22;24(17):13039. doi: 10.3390/ijms241713039. Int J Mol Sci. 2023. PMID: 37685846 Free PMC article.
-
Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.Neuropsychopharmacology. 2014 Mar;39(4):1031-8. doi: 10.1038/npp.2013.306. Epub 2013 Oct 29. Neuropsychopharmacology. 2014. PMID: 24165886 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical